Sen. Richard Blumenthal (D-Conn.) is calling on the Department of Justice (DOJ) to reject a settlement with the maker of EpiPens and instead press on with its investigation of the company, Mylan.
Blumenthal's call comes after an announcement by Mylan earlier this month that it had reached a $465 million settlement with the DOJ over claims that the company overcharged the Medicaid program for years by misclassifying EpiPens as the wrong type of drug.
